FTYPX
Price
$28.84
Change
-$0.30 (-1.03%)
Updated
Aug 18 closing price
Net Assets
24.39B
JFFYX
Price
$34.25
Change
-$0.40 (-1.15%)
Updated
Aug 18 closing price
Net Assets
1.97B
Interact to see
Advertisement

FTYPX vs JFFYX

FTYPX vs JFFYX Comparison Chart in %
View a ticker or compare two or three
VS
FTYPX vs. JFFYX commentary
Aug 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTYPX is a Hold and JFFYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTYPX has more cash in the bank: 24.4B vs. JFFYX (1.97B). JFFYX pays higher dividends than FTYPX: JFFYX (2.00) vs FTYPX (1.75). FTYPX was incepted earlier than JFFYX: FTYPX (6 years) vs JFFYX (12 years). JFFYX (0.41) is less costly to investors than FTYPX (0.05). JFFYX is a more actively managed with annual turnover of: 14.00 vs. FTYPX (13.00). JFFYX has a lower initial minimum investment than FTYPX: JFFYX (15000000) vs FTYPX (2000000000). FTYPX annual gain was more profitable for investors over the last year : 22.27 vs. JFFYX (15.48). FTYPX return over 5 years is better than : 62.87 vs. JFFYX (28.38).
FTYPXJFFYXFTYPX / JFFYX
Total Expense Ratio0.050.3913%
Annual Report Gross Expense Ratio0.050.4112%
Fund Existence6 years12 years-
Gain YTD14.56112.720114%
Front LoadN/AN/A-
Min. Initial Investment20000000001500000013,333%
Min. Initial Investment IRAN/AN/A-
Net Assets24.4B1.97B1,241%
Annual Yield % from dividends1.752.0087%
Returns for 1 year22.2715.48144%
Returns for 3 years73.5762.24118%
Returns for 5 years62.8728.38222%
Returns for 10 yearsN/A101.81-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TME8.79-0.08
-0.90%
Tencent Music Entertainment Group
VRAX2.76-0.05
-1.78%
Virax Biolabs Group Limited
XXI4.84-0.11
-2.22%
Twenty One Capital Inc.
WATT14.23-0.52
-3.53%
Energous Corporation
KYTX8.50-0.45
-5.03%
Kyverna Therapeutics